The U.S. Food and Drug Administration (FDA) has clearly indicated that extension of the current “partial shutdown” of the government will, in the not too distant future, start to delay approvals of new drugs and diagnostics and new indications for currently marketed drugs. … READ MORE …
Filed under: Uncategorized | Tagged: approval, diagnostic, drug | Leave a comment »
Here’s a clear signal that prostate cancer is entering the world of targeted therapeutics associated with specific companion diagnostics: the Canadian company Aeterna Zentaris has announced a partnership to develop a companion diagnostic to identify patients likely to respond to their targeted therapy AEZS-108. … READ MORE …
Filed under: Drugs in development | Tagged: AEZS-108, diagnostic, drug, targeting | Leave a comment »
In today’s prostate cancer news update we report on:
Filed under: Diagnosis, Prevention | Tagged: awareness, cancer, diagnostic, news, PHP94, prostate, PSA, risk, test, update | Leave a comment »
Health Discovery Corporation (HDC) has announced the successful completion of a double-blind, Phase III trial of its new gene-based molecular diagnostic test for prostate cancer. … READ MORE …
Filed under: Diagnosis | Tagged: cancer, diagnostic, gene-based, news, prostate, test, update | 4 Comments »
